Financials

  • Market Capitalization 556.27 M
  • Employee 231
  • Founded 2015
  • CEO N/A
  • Website www.prokidney.com
  • Headquarter Cayman Islands
  • FIGI BBG0119BQ2Y2
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-4.31
Price to sales ratio
335.98

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
2869
CABA
Cabaletta Bio, Inc. - Common Stock
3.12 USD-7.69%-0.32%+14.71%+106.62%528.98 M USD
2870
ZURA
Zura Bio Limited - Class A Ordinary shares
5.73 USD-2.05%-2.05%+3.43%+170.28%549.10 M USD
2890
ENTX
Entera Bio Ltd. - Ordinary Shares
3.04 USD-1.30%-5.88%-5.59%+52.00%526.35 M USD
2894
KYTX
Kyverna Therapeutics, Inc. - Common Stock
8.36 USD-3.24%-0.71%+11.47%+114.36%517.01 M USD

Frequently asked questions about ProKidney Corp. Class A Ordinary Shares

What is the ProKidney Corp. Class A Ordinary Shares stock price today?

The current price of ProKidney Corp. Class A Ordinary Shares (PROK) is 1.84. Over the past 24 hours, the stock has changed by +1.10%. Follow the PROK chart for real-time price dynamics.

What is the stock ticker of ProKidney Corp. Class A Ordinary Shares?

ProKidney Corp. Class A Ordinary Shares trades under the ticker PROK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is ProKidney Corp. Class A Ordinary Shares stock going up?

PROK has changed by +14.29% over the last week, +17.95% over the last month, and -11.54% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of ProKidney Corp. Class A Ordinary Shares?

ProKidney Corp. Class A Ordinary Shares currently has a market capitalization of 556.27 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What were ProKidney Corp. Class A Ordinary Shares earnings last quarter?

Last quarter, ProKidney Corp. Class A Ordinary Shares reported earnings of -0.15 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

What was ProKidney Corp. Class A Ordinary Shares revenue for the last quarter?

ProKidney Corp. Class A Ordinary Shares reported quarterly revenue of 150 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

What was ProKidney Corp. Class A Ordinary Shares net income for the last quarter?

ProKidney Corp. Class A Ordinary Shares reported net income of -28.42 M for the last quarter. The previous quarter showed -20.04 M, which means net income changed by -41.85%.

How many employees does ProKidney Corp. Class A Ordinary Shares have?

As of the latest available data, ProKidney Corp. Class A Ordinary Shares has 231 employees. Workforce size can provide additional context about the company's scale and operations.

What is ProKidney Corp. Class A Ordinary Shares EBITDA?

ProKidney Corp. Class A Ordinary Shares EBITDA is -46.7 M, and its EBITDA margin is -31.13 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy ProKidney Corp. Class A Ordinary Shares stock?

You can buy ProKidney Corp. Class A Ordinary Shares (PROK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in ProKidney Corp. Class A Ordinary Shares stock?

Investing in ProKidney Corp. Class A Ordinary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PROK chart and related analysis on metatrader.com as part of your research.

News